AU7669496A - Method for the intranasal administration of l-dopa prodrugs - Google Patents

Method for the intranasal administration of l-dopa prodrugs

Info

Publication number
AU7669496A
AU7669496A AU76694/96A AU7669496A AU7669496A AU 7669496 A AU7669496 A AU 7669496A AU 76694/96 A AU76694/96 A AU 76694/96A AU 7669496 A AU7669496 A AU 7669496A AU 7669496 A AU7669496 A AU 7669496A
Authority
AU
Australia
Prior art keywords
method
intranasal administration
dopa prodrugs
dopa
prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76694/96A
Inventor
Lewis Dittert
Anwar A. Hussain
Soichi Itoh
Huaihung Danny Kao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky
Original Assignee
University of Kentucky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US55277795A priority Critical
Priority to US552777 priority
Application filed by University of Kentucky filed Critical University of Kentucky
Priority to PCT/US1996/017740 priority patent/WO1997016181A1/en
Publication of AU7669496A publication Critical patent/AU7669496A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
AU76694/96A 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs Abandoned AU7669496A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US55277795A true 1995-11-03 1995-11-03
US552777 1995-11-03
PCT/US1996/017740 WO1997016181A1 (en) 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs

Publications (1)

Publication Number Publication Date
AU7669496A true AU7669496A (en) 1997-05-22

Family

ID=24206768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76694/96A Abandoned AU7669496A (en) 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs

Country Status (2)

Country Link
AU (1) AU7669496A (en)
WO (1) WO1997016181A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4516A (en) 1997-07-01 1999-01-02 Gizurarson Sveinbjörn new formulations
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
JP2011520788A (en) 2008-04-18 2011-07-21 アリゾナ ボード オブ リージェンツ ア ボディー コープ.オブ ザ ステイト オブ アリゾナ アクティング フォー アンド オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナArizona Board Of Regents,A Body Corp.Of The State Of Arizona,Acting For And On Behalf Of The University Of Arizona Method for identifying a compound for treating methods and compositions as well as age-related macular degeneration treating age related macular degeneration
AU2016348638A1 (en) 2015-11-06 2018-06-07 Gemphire Therapeutics Inc. Gemcabene combinations for the treatment of cardiovascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663349A (en) * 1985-12-30 1987-05-05 Merck & Co., Inc. Rectally absorbable form of L-dopa
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA

Also Published As

Publication number Publication date
WO1997016181A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU695194B2 (en) Dosage form comprising oxybutynin
AU694635B2 (en) Arylsulfonyl hydroxamic acid derivatives
AU686497B2 (en) Female component for refastenable fastening device
AU697991B2 (en) CD16-II variants
AU689370B2 (en) Earmuff
AU678494B2 (en) Improved prodrugs for enzyme medicated activation
EP1109274B8 (en) Connector
AU5826896A (en) Toothbrush
AU4773696A (en) Toothbrush
AU6687296A (en) Method of disinfecting the air
AU6927796A (en) Toothbrush
AUPN060095A0 (en) Apparatus for biomass production
AU6612396A (en) Toothbrush
AU6883798A (en) Method of anesthesia
AUPN564395A0 (en) Multivenue jackpot system
AU7662896A (en) Method for the production of hybrid plants
AU6785996A (en) 2-alkylpyrrolidines
AU7593796A (en) Method for manufacturing diffusors for shower heads
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU6314396A (en) Drinks-dispensing apparatus
AU5873696A (en) Method of preparing 3-haloalkyl-1h-pyrazoles
AU2612097A (en) I * Doll
AU4780896A (en) Core-board
AU6391796A (en) Pyridinone-thrombin inhibitors
AU4844396A (en) Imidazoquinazoline derivatives